SkinHealth Systems Inc. Income (Loss) from Continuing Operations before Income Taxes, Domestic
SkinHealth Systems Inc. (SKIN) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$12.46 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-12
- SkinHealth Systems Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$12.46M.
- SkinHealth Systems Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$28.33M.
- SkinHealth Systems Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$104.16M, a 347.53% decline from fiscal 2022.
- SkinHealth Systems Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was $42.08M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$12.46M 10-K · filed 2026-03-12 | |
| 2024-12-31 | -$28.33M 10-K · filed 2026-03-12 | |
| 2023-12-31 | -$104.16M 10-K · filed 2026-03-12 | |
| 2022-12-31 | $42.08M 10-K · filed 2025-03-12 | $43.64M 10-K · filed 2023-03-01 |
| 2021-12-31 | -$378.83M 10-K · filed 2024-03-12 | -$375.54M 10-K · filed 2022-03-01 |
| 2020-12-31 | -$40.13M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |